[PERSON]
Roland Buhl
Featured in 1 tracked story · first seen
Situations
Celltrion Omlyclo European market expansion
2 clusters · 6 sources · last updated
Latest: Celltrion's Omlyclo expands in Europe with 90% market share in Spain
Celltrion has expanded the availability of Omlyclo, its omaliizumab biosimilar for allergic asthma and chronic spontaneous urticaria, across major European markets. Following the initial release of 75mg and 150mg doses,